The Incidental Economist

Contemplating health care with a focus on research, an eye on reform.


  • About the blog
  • FAQ
  • Podcast archive
  • Site policies
  • TIE-U
  • Authors

    Austin Frakt Google+ twitter facebook email
    Aaron Carroll twitter facebook email
    Kevin Outterson twitter facebook email
    Harold Pollack twitter facebook email
    Bill Gardner Google+ twitterfacebook email
    Other Contributors
  • Recent posts

    • Fluoridation
    • How to debate a wing nut
    • Chart of the day: Cognitive ability and enrollment into public programs
    • Cutting the budget for inspections of compounding pharmacies
    • Sound Medicine: Why are employers offering health care incentives?
    • “Body Ritual among the Nacirema”
    • A conversation with Keith Humphreys on health reform, mental health, and substance abuse treatment
    • Micro and macro totems
    • Bias, validity, and terminology
    • The sequester is hurting mental health research
  • Archives

  • For speaking inquiries


    Interested in having Aaron or Austin speak to your group?

    For information on Aaron speaking, click here.

    For information on Austin speaking, click here.

  • Aaron’s stuff

    Selected appearances:
    The Colbert Report
    Good Morning America
    Sound Medicine (most recent)
    The Ed Show

  • Austin’s stuff

    Click here for a link to Austin's CV, as well as a complete list of his peer-reviewed publications with links to related posts and/or ungated versions (when available).

  • All about big pharma [FAQ]

      4 comments
      September 10, 2012 at 12:30 pm
      Austin Frakt

    This is a FAQ entry. See the main FAQ index for others.

    Aaron has done a lot of blogging on big pharma. He emailed me what he thinks is a comprehensive list of his posts to date:

    • The majority of research cited in pharma patent applications was done in academic centers, 15% by the industry [chart]
    • Don’t we need to pay for innovation?
    • How the industry uses patent infringement suits
    • Pharma and the free market
    • How the industry pays their competitors to keep cheaper generic competition off the shelves
    • How much the industry spends on promotion vs. R&D
    • The inner workings of the pharmaceutical industry
      • Part 1 [charts]
      • Part 2 [chart]
      • Part 3
      • Part 4
    • How drugs contribute to making the US health system so expensive
    • Despite the spending, many people can’t afford to take recommended medications
    • The bizarre support for drug importation
    • Spreading the blame around for pharmaceutical policy
    • Newer drugs aren’t always better

    @afrakt

    TwitterFacebookDiggDeliciousStumbleUponShare
      4 comments on this post
     
      Health Policy
      FAQ, pharma
    • Comments (4)

    • by pcm4 on September 10th, 2012 at 12:21

      The link “How much the industry spends on promotion vs. R&D” is not working for me. Tried it a few times.

      Reply

      [top]
      • by Austin Frakt on September 10th, 2012 at 12:43

        Fixed! Thanks.

        Reply

        [top]
    • by Floccina on September 11th, 2012 at 11:58

      I think that we could live without patent but if we have patent I do not see how we could justify denying it to big Pharma. If what I read is correct patent system does not work well or the way most people assume it works. I would like to see serious patent reform.

      Reply

      [top]
    • by Politics Debunked on May 11th, 2013 at 20:24

      Since this is a FAQ I’ll comment here on an old page rather than on the link. I’d suggest some on this blog need to read up on how innovation spreads. One of the links on this page claims “You know what needs no promotion? Awesome new drugs that save lives. ” Try looking up the book “Diffusion of Innovation”, an academic work which points out how even free life saving innovations *don’t* automatically spread quickly, there is resistance to change even to new and better things. Yes, it does vary by culture, but often people vastly overestimate how easy it is. (talk to the many startup companies that failed due to poor marketing despite a great product). Or books on tech marketing like “Crossing the Chasm”, innovations can be costly to spread. Economists need to have more of a grounding in how the business world really works, rather than naive fantasies.

      Yes, they may spend too much on marketing&promotion for various reasons. That is complicated and in part due to ways this isn’t a free market, where regulatory capture and a badly broken approval process slows competition (which tends to force companies to be less wasteful) and interferes in ways I don’t have time to go into now, a ripple of unintended consequences of bad policies throughout the system. I’ll just suggest that if you folks are going to be covering a business realm, you folks need to consider descending from the ivory tower higher level of economics and learn to think like entrepreneurs and investors and business people. (based also on the comments on profit and other topics as well).

      Reply

      [top]

    Write a comment

    Click here to cancel reply.




    (Submission implies acceptance of comments policy.)

    Loading

  • Follow the blog

    rss Google+ twitter facebook facebook

    Why all these options?

  • TIE Books

    Don't Cross Your Eyes! Amazon.com
    Barnes & Noble
    Books-A-Million
    Borders
    IndieBound


    Don't Swallow Your Gum!
    Borders
    Barnes & Noble
    IndieBound
    Amazon.com
    Books-A-Million
  • Tag cloud

    AcademyHealth accountable care organizations Affordable Care Act announcement antitrust blogging books comic competitive bidding costs cost shifting deficit employer-sponsored health insurance health care costs health insurance health insurance mandates health reform hospital readmissions hospitals instrumental variables insurance exchange market power Massachusetts Medicaid Medicare mortality obesity On The Record physicians politics PPACA premiums premium support prescription drugs prostate cancer quality reading list reflex RWJF single payer spending substance use tax uninsured xkcd
Work posted here under copyright © of the authors.

Details on the Site Policies page.